Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Colorectal Neoplasms 4 Prostatic Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Pain 2 Motor Activity 2 Hematopoietic and Lymphatic System Neoplasm 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sedentary Behavior 1 Sarcoma 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pulmonary Disease, Chronic Obstructive 1 Polyps 1 Patient Satisfaction 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neuromuscular Junction Diseases 1 Nervous System Diseases 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Muscle Weakness 1 Metastatic Pancreatic Adenocarcinoma 1 Malignant Hepatobiliary Neoplasm 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 30 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Radiotherapy 16 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Nivolumab 13 Ramucirumab 11 Cyclophosphamide 11 Drug Therapy 9 Trastuzumab 8 Erlotinib Hydrochloride 8 zolbetuximab 7 Taxes 7 Radiosurgery 7 trastuzumab deruxtecan 6 cemiplimab 6 Blood Specimen Collection 6 regorafenib 5 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Telemedicine × Clear all

NCT04667403 2022-04-28

PANTELO

Institut Cancerologie de l'Ouest

Phase NA Unknown

Adenocarcinoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡